Medicare Coverage Heals A Painful Summer For Cytomedix (CMXI)

Alan Masterson - August 6, 2012

A dismal summer for Cytomedix (OTC: CMXI) stock suddenly turned a little brighter today. The Centers for Medicare and Medicaid Services announced that they had approved coverage for autologous blood-derived products (the patient’s...

Sign Up To Get Our Latest Stocks Alerts